Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q
- PMID: 3262124
- PMCID: PMC303588
- DOI: 10.1172/JCI113684
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q
Abstract
The majority of C1q-binding IgG in sera of some patients with systemic lupus erythematosus (SLE) cosediments with monomeric IgG. This study was undertaken to provide definitive proof that the low-molecular weight C1q-binding IgG consists of autoantibodies to C1q. Monomeric C1q-binding IgG was isolated from five SLE plasmas by C1q affinity chromatography and gel filtration. All C1q-binding IgG preparations and their F(ab')2 fragments bound to both C1q and the collagen-like region of C1q by an ELISA. To rule out the possibility that small DNA-antiDNA immune complexes caused this binding activity, Fab' fragments of the C1q-binding IgG preparations were digested with DNase I to degrade any DNA. The Fab' fragments continued to bind to C1q and its collagen-like region after this treatment. C1q-binding IgG was heterogenous on isoelectric focusing. Interaction of C1q-binding IgG with solid-phase C1q was retained in 1 M NaCl, whereas the binding of DNA or heat-aggregated IgG to solid-phase C1q was abrogated or markedly diminished. The association constant of C1q-binding IgG with solid-phase C1q was 2.7 X 10(7) M-1. We conclude that low-molecular weight C1q-binding IgG in the studied patients with SLE consists of autoantibodies to the collagen-like region of C1q.
Similar articles
-
C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.Clin Exp Immunol. 1987 Jul;69(1):98-106. Clin Exp Immunol. 1987. PMID: 3498589 Free PMC article.
-
Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.Arthritis Rheum. 1988 Apr;31(4):457-64. doi: 10.1002/art.1780310401. Arthritis Rheum. 1988. PMID: 3258749
-
Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.Arthritis Rheum. 1989 May;32(5):544-51. doi: 10.1002/anr.1780320506. Arthritis Rheum. 1989. PMID: 2785797
-
Chemistry and molecular genetics of C1q.Behring Inst Mitt. 1989 Jul;(84):8-19. Behring Inst Mitt. 1989. PMID: 2679537 Review.
-
Characterization of the human C1q receptor.Behring Inst Mitt. 1989 Jul;(84):216-9. Behring Inst Mitt. 1989. PMID: 2679534 Review.
Cited by
-
Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.J Clin Invest. 2004 Sep;114(5):616-9. doi: 10.1172/JCI22820. J Clin Invest. 2004. PMID: 15343378 Free PMC article.
-
Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.J Immunol Methods. 2014 Jan 15;402(1-2):23-34. doi: 10.1016/j.jim.2013.11.004. Epub 2013 Nov 20. J Immunol Methods. 2014. PMID: 24269750 Free PMC article.
-
The Pathogenesis of Lupus Nephritis.J Clin Cell Immunol. 2014 Apr;5(2):205. doi: 10.4172/2155-9899.1000205. J Clin Cell Immunol. 2014. PMID: 25133068 Free PMC article.
-
High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis.Clin Rheumatol. 2008 Nov;27(11):1417-21. doi: 10.1007/s10067-008-0939-4. Epub 2008 Jun 4. Clin Rheumatol. 2008. PMID: 18523820
-
Autoantibodies against complement component C1q in systemic lupus erythematosus.Clin Transl Immunology. 2021 Apr 29;10(4):e1279. doi: 10.1002/cti2.1279. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33968409 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous